Tonix Pharmaceuticals Holding Corp. (TNXP) Debt by Year
Tonix Pharmaceuticals Holding Corp. held $207.6M in cash and equivalents at the end of fiscal year 2025, and long-term debt is not reported for that period. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Tonix Pharmaceuticals Holding Corp. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
TNXP Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | N/A | $4.7M-28.9% | $6.6M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $207.6M+110.2% | $98.8M+295.9% | $24.9M-79.2% | $120.2M-32.7% | $178.7M+131.8% | $77.1M+585.1% | $11.2M-55.1% | $25.0M-1.8% | $25.5M+34.6% | $18.9M-1.2% | $19.2M-49.8% | $38.2M+365.5% | $8.2M+359.5% | $1.8M+4253.7% | $41K |
TNXP Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | $4.7M-28.9% | $5.2M | $5.7M | $6.2M | $6.6M | N/A |
| Cash & Equivalents | $176.2M+40.6% | $185.5M+40.8% | $207.6M+110.2% | $190.1M+573.2% | $125.3M+2915.7% | $131.7M+1768.6% | $98.8M+295.9% | $28.2M+308.3% | $4.2M-83.8% | $7.0M-90.2% | $24.9M-79.2% | $6.9M-95.1% |
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More Tonix Pharmaceuticals Holding Corp. financials
Frequently Asked Questions
What was Tonix Pharmaceuticals Holding Corp.'s long-term debt in fiscal year 2025?
Tonix Pharmaceuticals Holding Corp. held $207.6M in cash and equivalents at the end of fiscal year 2025, and long-term debt is not reported for that period.
What does long-term debt mean on a financial statement?
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Tonix Pharmaceuticals Holding Corp. (TNXP) reported on that line in every period on record.